---
title: Clinical Research Coordinator Society (CRCS) Forums
permalink: /crcs-forums/
variant: tiptap
description: ""
third_nav_title: Other Courses & Events
---
<h4><strong>About CRCS Forums</strong></h4>
<p>The CRCS is a community comprising clinical research coordinators across
various public healthcare institutions in Singapore. CRCS seeks to address
the training and educational needs for clinical research coordinators involved
in supporting the conduct of research studies.
<br>
<br>As part of these educational efforts, CRCS forums are held several times
a year, as a platform for information sharing, exchange of ideas and networking
across the community. CRCS also collaborates with the Clinical Research
Professional (CRP) community in Singapore in organizing these educational
initiatives.
<br>&nbsp;<strong>&nbsp;</strong>
</p>
<h4><strong>Past CRCS Forums</strong></h4>
<p>Presentation materials (with speakers’ agreement) from past CRCS forums
are available for download below:</p>
<p></p>
<div data-type="detailGroup" class="isomer-accordion-group isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS Forum (26 Jan 2024)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="https://www.hsa.gov.sg/docs/default-source/hprg-io-ctb/slides-gcp/looking-back-at-2023-(crcs_26jan2024).pdf?sfvrsn=57cdd965_2" rel="noopener noreferrer nofollow" target="_blank"><u>Looking Back at 2023</u></a></strong>
<br>By Sumitra Sachidanandan, Regulatory Consultant
<br>Innovation Office &amp; Clinical Trials Branch
<br>Health Products Regulation Group
<br>Health Sciences Authority Singapore</p>
<p></p>
</li>
<li>
<p><strong><a href="https://for.sg/ecos-migrationprep" rel="noopener noreferrer nofollow" target="_blank"><u>Updates from NHG: Get Ready for ECOS &amp; Updates to Minimum Training Requirements for DSRB submissions</u></a></strong>
<br>Ms Zhang Cailian, Specialist
<br>Office of Human Research Protection Programme, NHG Group Research &amp;
Innovation</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<div data-type="detailGroup" class="isomer-accordion-group isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS Forum (6 Jan 2023)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="https://www.hsa.gov.sg/docs/default-source/hprg-io-ctb/slides-gcp/looking-back-at-2022-(crcs_6jan2023).pdf?sfvrsn=4c22ebff_4" rel="noopener noreferrer nofollow" target="_blank"><u>Looking Back at 2022</u></a></strong>
<br>Sumitra Sachidanandan, Regulatory Consultant
<br>Innovation Office &amp; Clinical Trials Branch
<br>Health Products Regulation Group
<br>Health Sciences Authority Singapore</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<div data-type="detailGroup" class="isomer-accordion-group isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (2 Jan 2022)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="https://www.hsa.gov.sg/docs/default-source/hprg-io-ctb/slides-gcp/looking-back-at-2020-2021-(crcs_20jan2022).pdf?sfvrsn=112718e9_2" rel="noopener noreferrer nofollow" target="_blank"><u>Looking Back at 2021</u></a></strong>
<br>Ms. Sumitra Sachidanandan, Regulatory Consultant - GCP Unit
<br>Innovation Office &amp; Clinical Trials Branch
<br>Medical Products Pre-market Cluster
<br>Health Products Regulation Group
<br>Health Sciences Authority Singapore</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<div data-type="detailGroup" class="isomer-accordion-group isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>SCRI-NHG CRCS Forum &amp; CRC Appreciation Day 2021</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><a href="/files/Training Files/CRCS Forum/20210331_Managing_impact_of_CT_during_COVID.pdf" rel="noopener noreferrer nofollow" target="_blank">Managing the impact of clinical trials during the COVID-19 pandemic</a>
<br>Ms. Sumitra Sachidanandan, Regulatory Consultant
<br>Innovation Office &amp; Clinical Trials Branch
<br>Health Products Regulation Group
<br>Health Sciences Authority Singapore</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<div data-type="detailGroup" class="isomer-accordion-group isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (3 Dec 2019)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="https://www.hsa.gov.sg/docs/default-source/hprg-io-ctb/looking-back-at-2019-(crcs_3dec2019).pdf?sfvrsn=a19a028c_2)" rel="noopener noreferrer nofollow" target="_blank"><u>Looking back at 2019</u></a></strong>
<br>Ms. Sumitra Sachidanandan, Regulatory Consultant – GCP Unit
<br>Innovation Office &amp; Clinical Trials Branch,
<br>Medicinal Products Pre-market Cluster,
<br>Health Products Regulation Group,
<br>Health Sciences Authority</p>
<p></p>
</li>
<li>
<p><strong><a href="https://www.research.nhg.com.sg/wps/wcm/connect/7dfb242b-df5c-4e7e-86ed-4e345806a1ed/CRC+forum+2019+Consent+requirements.pdf?MOD=AJPERES&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb&amp;CVID=nfxGqEb" rel="noopener noreferrer nofollow" target="_blank"><u>Requirement of Appropriate Consent for Conduct of Human Biomedical Research and Handling of Human Tissue</u></a></strong>
<br>Dr. May Thu MA
<br>Senior Manager, Biomedical Research Regulation Branch, Regulatory Compliance
&amp; Enforcement Division, Health Regulation Group, Ministry of Health</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<p></p>
<div data-type="detailGroup" class="isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (07 Dec 2018)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2018/Looking_back_at_2018_7_Dec_2018.pdf" rel="noopener noreferrer nofollow" target="_blank">Looking back at 2018 </a></strong>
<br>Ms Sumitra Sachidanandan
<br>Regulatory Consultants - GCP Unit, Innovation Office &amp; Clinical Trials
Branch, Medicinal Products Pre-market Cluster, Health Products Regulation
Group, HSA</p>
</li>
</ul>
<p></p>
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2018/Post_Activation_of_Human_Biomedical_Research_Act_7_Dec_2018.pdf" rel="noopener noreferrer nofollow" target="_blank">Post Activation of Human Biomedical Research Act: Compliance and Risks </a></strong>
<br>Dr Yeo Jing Ping
<br>Director, Office of Research Integrity, Compliance and Ethics, SingHealth</p>
</li>
</ul>
<p></p>
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2018/Monitoring_Programme_for_Human_Biomedical_Research_Studies_7_Dec_2018.pdf" rel="noopener noreferrer nofollow" target="_blank">Monitoring Programme for Human Biomedical Research Studies </a></strong>
<br>Ms Jaslin Tan Shen Fong
<br>Senior Executive, Research Quality Management Unit, Research &amp; Development
Office, National Healthcare Group (NHG)</p>
<p></p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (14 Sep 2018)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2018/Developing_Sound_Communication_And_Interpersonal_Skills_14_Sep_2018.pdf" rel="noopener noreferrer nofollow" target="_blank">CRCs/CRPs and CIS: Developing Sound Communication and Interpersonal Skills (CIS) Is Essential for Success </a></strong>
<br>Dr Aamir Shaikh, MD, DPBM
<br>Founder, Health Care Consultant, Assansa</p>
</li>
</ul>
<p></p>
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2018/Conflict_Management_14_Sep_2018.pdf" rel="noopener noreferrer nofollow" target="_blank">Conflict Management / Problem Solving </a></strong>
<br>Mr Nelson Wong
<br>Founder &amp; Director, CSI Medical Research</p>
</li>
</ul>
<p></p>
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2018/Why_Service_Excellence_Matters_14_Sep_2018.pdf" rel="noopener noreferrer nofollow" target="_blank">Why Service Excellence Matters and How to EXC3ITE (Execute) It?</a></strong> 
<br>Mr Chan Peng, Tech Observer Asia Pacific</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<p></p>
<div data-type="detailGroup" class="isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (1 Dec 2017)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2017/Implications_for_Investigator_Initiated_Trials_1_Dec_2017.pdf" rel="noopener noreferrer nofollow" target="_blank">Implications for Investigator Initiated Trials - Risk Based Approaches in Managing Clinical Trials </a></strong>
<br>Ms. Lisa Marie Saldanha, IQVIA</p>
</li>
</ul>
<p></p>
<ul data-tight="true" class="tight">
<li>
<p><strong>Looking Back at the Changes in Clinical Trials and CRM Regulations</strong> 
<br>The presentation shared by HSA can be accessed <a href="http://www.hsa.gov.sg/content/hsa/en/Health_Products_Regulation/Clinical_Trials/Industry_Communication.html" rel="noopener nofollow" target="_blank">accessed here</a>.</p>
<p></p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (25 Aug 2017)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2017/Issue_Management_and_Quality_Risk_Management_Implications.pdf" rel="noopener noreferrer nofollow" target="_blank">Issue Management / Quality Risk Management Implications with ICH GCP E6 (R2) and ISO 31000 and Implementation within Quality System</a></strong>
</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2017/Data_integrity_in_Clinical_Research.pdf" rel="noopener noreferrer nofollow" target="_blank">Data integrity in Clinical Research - Expectations and Considerations for Quality Control and Assurance</a></strong>
</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2017/Identification_of_Critical_Data_and_Processes_in_Clinical_Trial.pdf" rel="noopener noreferrer nofollow" target="_blank">Identification of Critical Data and Processes in Clinical Trial and Incorporation of Risk Mitigation into Protocol</a></strong>
</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2017/Ensuring_GCP_Compliance_in_Investigator_Initiated_Trials.pdf" rel="noopener noreferrer nofollow" target="_blank">Ensuring GCP Compliance in Investigator Initiated Trials (IITs) - A Case Study</a></strong>
</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<p></p>
<div data-type="detailGroup" class="isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (9 Dec 2016)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2016/Risk_based_monitoring_9_Dec_2016.pdf" rel="noopener noreferrer nofollow" target="_blank">Risk-based monitoring: After Years of talking about it, where are we now?</a></strong>
</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2016/Human_Biomedical_Research_Act_9_Dec_2016.pdf" rel="noopener noreferrer nofollow" target="_blank">Human Biomedical Research Act: Scope and Regulatory Framework</a></strong>
</p>
<p></p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (26 Aug 2016)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2016/PDPA_Updates_Management_and_Protection_of_Patients_Data_26_Aug_2016.pdf" rel="noopener noreferrer nofollow" target="_blank">PDPA Updates: Management and Protection of Patients’ Data </a></strong>
<br>Mr Benjamin Cheong, Rajah &amp; Tann Singapore LLP</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2016/Considerations_for_Using_Electronic_Medical_Records_26_Aug_2016.pdf" rel="noopener noreferrer nofollow" target="_blank">Considerations for Using Electronic Medical Records (EMR) in Clinical Trials </a></strong>
<br>Mr Alex Goh, GlaxoSmithKline Pharmaceuticals</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2016/Management_of_Electronic_Trial_Master_Files_and_Essential_Documents_26_Aug_2016.pdf" rel="noopener noreferrer nofollow" target="_blank">Management of Electronic Trial Master Files and Essential Documents in Pharma and CROs </a></strong>
<br>Ms Jingyi Lin, PAREXEL</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2016/Using_Electronic_Patient_Reported_Outcomes__ePRO__in_Clinical_Trials_26_Aug_2016.pdf" rel="noopener noreferrer nofollow" target="_blank">Using Electronic Patient-Reported Outcomes (ePRO) in Clinical Trials: Lessons Learnt </a></strong>
<br>Ms Chong Pei-Fen, Quintiles</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<p></p>
<div data-type="detailGroup" class="isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (3 Dec 2015)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="http://www.hsa.gov.sg/content/dam/HSA/HPRG/Clinical_Trials/GCP/Common%20GCP%20Inspection%20Findings_2015%20%28CRP-CRCS_3Dec2015%29.pdf" rel="noopener nofollow" target="_blank">Updates from the GCP Inspection Team</a></strong>
<br>Ms Sumitra Sachidanandan, Health Sciences Authority
<br>
</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (28 Aug 2015)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2015/Ethically_and_scientifically_sound_28_Aug_2015.pdf" rel="noopener noreferrer nofollow" target="_blank">Ethically and scientifically sound: Actual reviews of applications involving vulnerable populations </a></strong>
<br>Dr Patricia Yap, IMH</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2015/Research_in_Children_Challenges_28_Aug_2015.pdf" rel="noopener noreferrer nofollow" target="_blank">Research in Children: Challenges </a></strong>
<br>Prof Quak Seng Hock, NUH</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2015/The_Process_of_Obtaining_Informed_Consent_in_Vulnerable_Population_28_Aug_2015.pdf" rel="noopener noreferrer nofollow" target="_blank">The Process of Obtaining Informed Consent in Vulnerable Population</a></strong> 
<br>Prof Swapna Verma, IMH</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<p></p>
<div data-type="detailGroup" class="isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>CRCS-CRP Forum (12 Dec 2014)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="http://www.hsa.gov.sg/content/dam/HSA/HPRG/Clinical_Trials/GCP/Common%20GCP%20Inspection%20Findings_2014%20(CRP-CRCS_12Dec2014).pdf" rel="noopener nofollow" target="_blank">Common GCP Inspection Findings for 2014</a></strong>
<br>Ms Sumitra Sachidanandan, HSA</p>
</li>
</ul>
<p></p>
<ul data-tight="true" class="tight">
<li>
<p>Serious Breaches
<br>Ms Poh Cuiqin, HSA
<br>(Slides not available)</p>
<p></p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>CRCS Forum (25 July 2014)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2014/Conducting_Monitoring_Visit_for_Investigator_Initiated_Studies_25_Jul_2014.pdf" rel="noopener noreferrer nofollow" target="_blank">Conducting Monitoring Visit for Investigator-Initiated Studies </a></strong>
<br>Mr Xia Yu, SCRI</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2014/Quality_Control_for_Phase_I_Trials___Site_Perspectives_25_Jul_2014.pdf" rel="noopener noreferrer nofollow" target="_blank">Quality Control for Phase I Trials – Site Perspectives </a></strong>
<br>Ms Yew Lay Hwa, CGH</p>
</li>
<li>
<p><strong><a href="/files/Training Files/CRCS Forum 2014/Impact_of_Personal_Data_Protectection_Laws_in_Clinical_Trials_25_Jul_2014.pdf" rel="noopener noreferrer nofollow" target="_blank">Impact of Privacy Laws in Clinical Trials </a></strong>
<br>Ms Rebecca Chew, Rajah &amp; Tann LLP</p>
<p></p>
</li>
</ul>
</div>
</details>
</div>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>